Dual Transcranial Direct Current Stimulation (dTDCS)-Enhanced Therapy After Hemorrhagic Strokes and VEGF

Stopped early · Not applicable · Has a placebo group

Conditions studied: Hemorrhagic Stroke, Hemiparesis

In brief

This study will evaluate the feasibility of dual tDCS to improve arm motor function in chronic stroke patients. In addition it will collect pilot data on the blood biomarkers associated with treatment effect.

Key facts

Study ID

NCT03857243

Run by

University of Texas Southwestern Medical Center

People needed

5

Starts

2014-01-01

Expected to finish

2017-04-17

Last updated by the study team

2019-11-18

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients (18-85 yo) with arm weakness (uFM <60) as a result of an ICH and no history of other neurologic or psychiatric illness that are able to activate wrist flexors (> MRC 1);
• Patients with symptomatic ICH >5 months before enrollment;
• Ashworth spasticity score <3.

You may not qualify if…

• Patients with severe uncontrolled medical problems,
• Patients with subarachnoid, subdural or epidural hemorrhage;
• Patients with unstable cardiac arrhythmia;
• Patients with contraindication to tDCS stimulation;
• Patients who are not available for follow-up or unable to follow study procedures;
• Pregnancy

Where it is running

• University of Texas Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.